N@N

Danielle Antalffy Maintained (ABT) at Hold with Increased Target to $140 on, Oct 21st, 2021

Danielle Antalffy of SVB Leerink, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $128 to $140 on, Oct 21st, 2021.

Danielle has made no other calls on ABT in the last 4 months.

There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021

These are the ratings of the 6 analyists that currently disagree with Danielle

---

• Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, October 20th, 2021
• Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
• Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021
• Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
• Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
• Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021

Contributing Sources

---